 |
Minimal deposit $50 Exclusive promotion |
Our score |
0% commission |
Are you looking to buy CEL SCI stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy AMEX:CVM! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about CEL SCI stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company’s lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia’s Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was founded in 1983 and is headquartered in Vienna, Virginia.
Average volume
1.76 million shs
MARKET CAP
$892.12 million
Stock exchange
NYSEAMERICAN
Buy this stock!
|
NAME
|
TICKER
|
INDUSTRY
|
SECTOR
|
VOLUME
|
BUY THIS STOCK NOW
|
|---|---|---|---|---|---|
|
AMEX:CVM
|
Biological products, except diagnostic
|
Medical
|
30,938 shs
|
Below is a quick guide on how to buy AMEX:CVM stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy CEL SCI shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy CEL SCI – Search for “”AMEX:CVM”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought CEL SCI stocks with 0% commission!.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
1 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for CEL-SCI in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should “buy” CEL-SCI stock.
Wall Street analysts have given CEL-SCI a “Buy” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but CEL-SCI wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing AMEX:CVM stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy CEL SCI stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy CEL SCI stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Now that you’ve funded your eToro account, just type “AMEX:CVM stocks” into the search bar at the top of the screen and press “trade”.
All that’s left is to buy some AMEX:CVM stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, AMEX:CVM is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy CEL SCI stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
CEL-SCI is scheduled to release its next quarterly earnings announcement on Monday, February 8th 2021.
View our earnings forecast for CEL-SCI.
CEL-SCI Co. (NYSEAMERICAN:CVM) posted its quarterly earnings results on Wednesday, December, 30th. The company reported ($0.14) earnings per share for the quarter. The business had revenue of $0.03 million for the quarter, compared to analysts’ expectations of $0.10 million. CEL-SCI had a negative net margin of 5,406.61% and a negative trailing twelve-month return on equity of 170.96%.
View CEL-SCI’s earnings history.
CEL-SCI’s stock was trading at $9.74 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CVM shares have increased by 120.6% and is now trading at $21.49.
CEL-SCI’s stock reverse split on the morning of Thursday, June 15th 2017. The 1-25 reverse split was announced on Monday, June 12th 2017. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, June 14th 2017. An investor that had 100 shares of CEL-SCI stock prior to the reverse split would have 4 shares after the split.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying AMEX:CVM stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
1 equities research analysts have issued 1 year target prices for CEL-SCI’s shares. Their forecasts range from $23.00 to $23.00. On average, they anticipate CEL-SCI’s share price to reach $23.00 in the next year. This suggests a possible upside of 7.0% from the stock’s current price.
View analysts’ price targets for CEL-SCI or view top-rated stocks among Wall Street analysts.
CEL-SCI’s management team includes the following people:
Mr. Geert R. Kersten, CEO, Principal Accounting & Financial Officer, Treasurer and Director (Age 62, Pay $825.53k)
Ms. Patricia B. Prichep, Sr. VP of Operations & Corp. Sec. (Age 70, Pay $383.35k)
Dr. Eyal Talor, Chief Scientific Officer (Age 65, Pay $317.48k)
Dr. Daniel H. Zimmerman, Sr. VP of Research & Cellular Immunology (Age 80, Pay $248.54k)
Mr. John Cipriano, Sr. VP of Regulatory Affairs (Age 79, Pay $237.04k)
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Some companies that are related to CEL-SCI include Sorrento Therapeutics (SRNE), Revolution Medicines (RVMD), Kymera Therapeutics (KYMR), NanoString Technologies (NSTG), bluebird bio (BLUE), AlloVir (ALVR), NantKwest (NK), Immunovant (IMVT), Translate Bio (TBIO), Bavarian Nordic A/S (BVNRY), Scholar Rock (SRRK), Vericel (VCEL), Sangamo Therapeutics (SGMO), Replimune Group (REPL) and C4 Therapeutics (CCCC).
View all of CVM’s competitors.
Based on aggregate information from Reportlab, some companies that other CEL-SCI investors own include Dynavax Technologies (DVAX), Inovio Pharmaceuticals (INO), TG Therapeutics (TGTX), Savara (SVRA), Molecular Templates (MTEM), Gilead Sciences (GILD), Heat Biologics (HTBX), Idera Pharmaceuticals (IDRA), VBI Vaccines (VBIV) and CymaBay Therapeutics (CBAY).
CEL-SCI trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol “CVM.”
CEL-SCI’s stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.22%), Avantax Advisory Services Inc. (0.30%), Swiss National Bank (0.21%), SG Americas Securities LLC (0.19%), State of Wisconsin Investment Board (0.18%) and Endurance Wealth Management Inc. (0.07%). Company insiders that own CEL-SCI stock include Geert R Kersten, John Cipriano, Patricia B Prichep and Peter R Young.
View institutional ownership trends for CEL-SCI.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
CVM stock was sold by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, State of Wisconsin Investment Board, Thoroughbred Financial Services LLC, and Pacer Advisors Inc..
View insider buying and selling activity for CEL-SCI or view top insider-selling stocks.
CVM stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., GSA Capital Partners LLP, Ingalls & Snyder LLC, Latitude Advisors LLC, Endurance Wealth Management Inc., Avantax Advisory Services Inc., Swiss National Bank, and Dynamic Advisor Solutions LLC. Company insiders that have bought CEL-SCI stock in the last two years include Geert R Kersten, Patricia B Prichep, and Peter R Young.
View insider buying and selling activity for CEL-SCI or or view top insider-buying stocks.
Shares of CVM can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interactive Brokers Review, eToro Review, DEGiro Review, AvaTrade Review, IG Markets Review, IC Markets Review, CMC Markets Review, Admiral Markets Review and many more. Read one of the reviews to find out everything about the broker and start buying stocks now.
One share of CVM stock can currently be purchased for approximately $21.49.
CEL-SCI has a market capitalization of $854.36 million and generates $560,000.00 in revenue each year. The company earns $-30,250,000.00 in net income (profit) each year or ($0.74) on an earnings per share basis.
The official website for CEL-SCI is www.cel-sci.com.
At Reportlab.org we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
How can you buy CEL SCI stock on the internet?
You can easily buy CEL SCI stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Another option is using a regulated broker like IC Markets or Interactive Brokers. You can an account with these brokers and start buying or trading AMEX:CVM stocks in a safe and complete environment to trade in.
Where to buy CEL SCI stock?
You will first want to find a licensed broker that supports AMEX:CVM stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading AMEX:CVM stocks in a safe and complete environment.
Is AMEX:CVM stock a good investment?
As with any other asset, there is an element of risk associated with buying AMEX:CVM stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is CEL SCI stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with AMEX:CVM is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in CEL SCI stock.
How do you trade CEL SCI stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for CEL SCI stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on AMEX:CVM stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell CEL SCI stock?
To sell your AMEX:CVM stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best CEL SCI stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading AMEX:CVM stock.
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
| Our score ★★★★★ | |
| Our score ★★★★★ | |
| Our score ★★★★★ |
Newsletter
Recent News
| |
Our score |
0% commission |
All EPA Stocks More Information EPA stocks What Is the Paris Stock Exchange (EPA)? Now
Realtime Stocks & Crypto data
Notifications, Tips & News
Best Stocks & Crypto Guides
Online Broker & Exchange Reviews
Reportlab Finance is purely an informative website and in no case implies investment advice. All investments carry risks and you can lose all your investments. Do not invest money that you cannot afford to lose.
Reportlab Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
United Kingdom
Copyright © 2022 Reportlab.Finance | All rights reserved.
